WHAT IS 'Biotech Compound'

Biotech compound refers to a chemical that shows potential for therapeutic application in the earliest stage of the development process. This stage is known as the drug discovery phase. It involves experimental modifications to the compound to identify the most promising candidate for further research in the next stage, known as drug development.

BREAKING DOWN 'Biotech Compound'

A biotech compound, also known as a lead compound, is an early but promising treatment for a disease. The first step in the selection of a biotech compound is the identification of a biological target. This is a molecule in the human body, most commonly a protein, which either causes a disease or modifies a disease in a way which complicates treatment. In order to remedy the effects of the malignant molecule, researchers determine whether the molecule needs to be inhibited or or stimulated. They will also consider the structure of the target molecule and consider compounds which will form the strongest structural bond with the target. Computer modeling is a recently common tool for identification of biotech compounds through structural analysis.

Biotech Compounds and Lipinski’s Rule of Five

Following the identification of a lead compound, researchers must modify the compound the optimize its therapeutic efficacy as well as its commercial viability. In 1997, Pfizer scientist Christopher Lipinski developed his Rule of Five which provides researchers with a set of guidelines, each based on a multiple of five, for the optimization of a compound’s pharmacokinetics. Pharmacokinetics refers to the study of medicines’ movement through the human body.

Although there are exceptions, Lipinski’s rule has come to be considered an important and useful starting point for the development of a biotech compound into a promising drug.  It allows researchers to scan digital compound libraries to identify biotech compounds that might show promise in addressing the biological target. The rule states that not more than one of the following criteria be violated in a candidate drug for oral consumption:

  1. The compound cannot have more than five nitrogen-hydrogen or hydrogen-hydrogen donor bonds.

  2. The compound cannot have more than ten hydrogen bond acceptors.

  3. The compound’s molecular mass must be smaller than 500 daltons.

  4. The compound’s octanol-water partition coefficient cannot exceed five.

Beyond the rule of five, a candidate compound must satisfy three criteria before it can move on to the development stage wherein it will be clinically tested on human subjects. First, it must bind sufficiently to the target molecule and show signs of eliciting the desired result in the target. Second, it must show signs of sufficient bioavailability and biodistribution in animals. Finally, it must pass toxicity testing in animals. Once these criteria are met, the lead compound becomes a drug suitable for clinical testing.

RELATED TERMS
  1. Compound

    Compound is the ability of an asset to generate earnings, which ...
  2. Compounding

    Compounding is the process in which an asset's earnings, from ...
  3. Compound Option

    A compound option is an option for which the underlying asset ...
  4. Stated Annual Interest Rate

    A stated annual interest rate is the return on an investment ...
  5. Put On A Call

    One of four compound options types, a put on a call is a put ...
  6. Automatic Reinvestment Plan

    An automatic reinvestment plan is a mutual fund plan that automatically ...
Related Articles
  1. Investing

    Continuous compound interest

    Different frequency in compound interest results in different returns. Check out how continuous compounding accelerates your return.
  2. Investing

    Overcoming Compounding's Dark Side

    Understanding how money is made and lost over time can help you improve your returns.
  3. Investing

    Learn simple and compound interest

    Interest is defined as the cost of borrowing money or the rate paid on a deposit to an investor. Interest can be classified as simple interest or compound interest.
  4. IPF - Banking

    How Interest Rates Work on Savings Accounts

    Here's what you need to know to grow your rainy-day fund.
  5. Insights

    The Biggest Biotech Companies

    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies carries significant risk.
  6. Investing

    A Biotech Sector Primer

    Investing in biotechs can involve both huge losses and major gains. Learn about the industry that focuses on novel drug development and clinical research.
  7. Investing

    Top 3 Biotech ETFs (XBI, IBB)

    Learn about three popular ETFs in the biotechnology sector, how they differ, and which ones may be appropriate for long term investors.
  8. Investing

    XBI: SPDR S&P Biotech ETF

    Discover the investment management style of SPDR S&P Biotech ETF, and learn which investors can benefit from the fund's focused biotech holdings.
RELATED FAQS
  1. Stated Annual Return vs Effective Annual Return

    The difference between these two measures is the effective annual return accounts for intra-year compounding, and the stated ... Read Answer >>
  2. How do I calculate compound interest using Excel?

    Learn how to calculate compound interest using three different techniques in Microsoft Excel. Read Answer >>
  3. Simple versus compound interest

    Different methods in interest calculation can end up different interest payment. Learn the differences between simple and ... Read Answer >>
  4. What does it mean when interest 'accrues daily?'

    Learn what it means when an interest-bearing account accrues interest daily and how different compounding periods change ... Read Answer >>
Trading Center